Brazilian Guidelines For The Treatment Of Narcolepsy [diretrizes Brasileiras Para O Tratamento Da Narcolepsia]

dc.creatorAloe F.
dc.creatorAlves R.C.
dc.creatorAraujo J.F.
dc.creatorAzevedo A.
dc.creatorBacelar A.
dc.creatorBezerra M.
dc.creatorBittencourt L.R.A.
dc.creatorBustamante G.
dc.creatorDe Oliveira Cardoso T.A.M.
dc.creatorEckeli A.L.
dc.creatorFernandes R.M.F.
dc.creatorGoulart L.
dc.creatorPradella-Hallinan M.
dc.creatorHasan R.
dc.creatorSander H.H.
dc.creatorPinto Jr. L.R.
dc.creatorLopes M.C.
dc.creatorMinhoto G.R.
dc.creatorMoraes W.
dc.creatorMoreira G.A.
dc.creatorPachito D.
dc.creatorPedrazolli M.
dc.creatorPoyares D.
dc.creatorPrado L.
dc.creatorRizzo G.
dc.creatorRodrigues R.N.
dc.creatorRoitman I.
dc.creatorSilva A.B.
dc.creatorTavares S.M.A.
dc.date2010
dc.date2015-06-26T12:37:44Z
dc.date2015-11-26T15:27:35Z
dc.date2015-06-26T12:37:44Z
dc.date2015-11-26T15:27:35Z
dc.date.accessioned2018-03-28T22:36:17Z
dc.date.available2018-03-28T22:36:17Z
dc.identifier
dc.identifierRevista Brasileira De Psiquiatria. , v. 32, n. 3, p. 305 - 314, 2010.
dc.identifier15164446
dc.identifier10.1590/S1516-44462010000300016
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-77958506725&partnerID=40&md5=6c6a85527763d5a1e7a92a9a1c726a43
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/91237
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/91237
dc.identifier2-s2.0-77958506725
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1261389
dc.descriptionThis manuscript contains the conclusion of the consensus meeting of the Brazilian Sleep Association with Brazilian sleep specialists on the treatment of narcolepsy based on the review of medical literature from 1980 to 2010. The manuscript objectives were to reinforce the use of agents evaluated in randomized placebo-controlled trials and to issue consensus opinions on the use of other available medications as well as to inform about safety and adverse effects of these medications. Management of narcolepsy relies on several classes of drugs, namely, stimulants for excessive sleepiness, antidepressants for cataplexy and hypnotics for disturbed nocturnal sleep. Behavioral measures are likewise valuable and universally recommended. All therapeutic trials were analyzed according to their class of evidence. Recommendations concerning the treatment of each single symptom of narcolepsy as well as general recommendations were made. Modafinil is the first-line pharmacological treatment of excessive sleepiness. Second-line choices for the treatment of excessive sleepiness are slow-release metylphenidate followed by mazindol. The first-line treatments of cataplexy are the antidepressants, reboxetine, clomipramine, venlafaxine, desvenlafaxine or high doses of selective serotonin reuptake inibitors antidepressants. As for disturbed nocturnal sleep the best option is still hypnotics. Antidepressants and hypnotics are used to treat hypnagogic hallucinations and sleep paralysis.
dc.description32
dc.description3
dc.description305
dc.description314
dc.descriptionMorgenthaler, T.I., Kapur, V.K., Brown, T., Swick, T.J., Alessi, C., Aurora, R.N., Boehlecke, B., Zak, R., Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin (2007) Sleep, 30 (12), pp. 1705-1711. , Standards of Practice Committee of the American Academy of Sleep Medicine
dc.descriptionSackett, D.L., Rules of evidence and clinical recommendations for the management of patients (1993) Can J Cardiol, 9 (6), pp. 487-489
dc.descriptionEddy, D., (1992) A Manual for Assessing Health Practices and Designing Practice Policies: The Explicit Approach, , Philadelphia: American College of Physicians
dc.descriptionLevels of Evidence, , http://www.cebm.net/index.aspx0=1025, Web Site. [cited 2009 dez 16]. Available from
dc.descriptionDelbecq, A., Vande Ven, A., A group process model for prob lem identification and programme planning (1971) J Appl Behav Sci, 7, pp. 467-492
dc.descriptionBritton, T., Hansen, A., Hicks, J., Howard, R., Meredith, A., (2002) Guidelines on the Diagnosis and Management of Narcolepsy in Adults and Children. Evidence-Based Guidelines for the UK with Graded Recommendations, , Ashtead, UK: Taylor Patten Communications Ltd
dc.descriptionGuilleminault, C., Fromherz, S., Narcolepsy: Diagnosis and management (2005) Principles and Practice of Sleep Medicine, , Kryger MH, Roth T, Dement WC, editors. 4th ed. Philadelphia: Saunders, Elsevier
dc.descriptionBilliard, M., Bassetti, C., Dauvilliers, Y., Dolenc-Groselj, L., Lammers, G.J., Mayer, G., Pollmacher, T., Sonka, K., EFNS guidelines on management of narcolepsy (2006) Eur J Neurol, 13 (10), pp. 1035-1048
dc.descriptionWise, M.S., Arand, D.L., Auger, R.R., Brooks, S.N., Watson, N.F., Treatment of narcolepsy and other hypersomnias of central origin (2007) Sleep, 30 (12), pp. 1712-1727
dc.descriptionRoehrs, T., Zorick, F., Wittig, R., Paxton, C., Sicklesteel, J., Roth, T., Alerting effects of naps in patients with narcolepsy (1986) Sleep, 9, pp. 194-199
dc.descriptionMullington, J., Broughton, R., Scheduled naps in the management of daytime sleepiness in narcolepsy- Cataplexy (1993) Sleep, 16 (5), pp. 444-456
dc.descriptionRogers, A.E., Aldrich, M.S., Lin, X., A comparison of three different sleep schedules for reducing daytime sleepiness in narcolepsy (2001) Sleep, 24 (4), pp. 385-391
dc.descriptionChen, W., Mignot, E., Narcolepsy and hypersomnia of central origin: Diagnosis, differential pearls, and management (2007) Review of Sleep Medicine, pp. 75-94. , Barkoukis T, Avidan A, editors. 2nd ed. Philadelphia: Butterworth Heinman, Elsevier
dc.descriptionZaharna, M., Dimitriu, A., Guilleminault, C., Expert opinion on pharmacotherapy of narcolepsy (2010) Expert Opin Pharmacother, , In press
dc.descriptionZolkowska, D., Jain, R., Rothman, R.B., Partilla, J.S., Roth, B.L., Setola, V., Prisinzano, T.E., Baumann, M.H., Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil (2009) J Pharmacol Exp Ther, 329 (2), pp. 738-746
dc.descriptionBoutrel, B., Koob, G.F., What keeps us awake: The neuropharmacology of stimulants and wakefulness-promoting medications (2004) Sleep, 27 (6), pp. 1181-1194
dc.descriptionVolkow, N.D., Fowler, J.S., Logan, J., Alexoff, D., Zhu, W., Telang, F., Hooker, J.M., Apelskog-Torres, K., Effects of modafinil on dopamine and dopamine transporters in the male human brain (2009) JAMA, 301 (11), pp. 1148-1154
dc.descriptionQu, W.M., Huang, Z.L., Xu, X.H., Matsumoto, N., Urade, Y., Dopamin ergic D1 and D2 receptors are essential for the arousal effect of modafinil (2008) J Neurosci, 28 (34), pp. 8462-8469
dc.descriptionBeierlein, M., Gibson, J.R., Connors, B.W., A network of electrically coupled interneurons drives synchronized inhibition in neocortex (2000) Nat Neurosci, 3 (9), pp. 904-910
dc.descriptionHestrin, S., Galarreta, M., Electrical synapses define networks of neocortical GABAergic neurons (2005) Trends in Neurosciences, 28 (6 SPEC. ISS), pp. 304-309. , DOI 10.1016/j.tins.2005.04.001, PII S0166223605000998
dc.descriptionGarcia-Rill, E., Heister, D.S., Ye, M., Charlesworth, A., Hayar, A., Electrical coupling: Novel mechanism for sleep-wake control (2007) Sleep, 30 (11), pp. 1405-1414
dc.descriptionUrbano, F.J., Leznik, E., Llinas, R.R., Modafinil enhances thalamocortical activity by increasing neuronal electrotonic coupling (2007) Proceedings of the National Academy of Sciences of the United States of America, 104 (30), pp. 12554-12559. , DOI 10.1073/pnas.0705087104
dc.descriptionBeck, P., Odle, A., Wallace-Hunt, T., Skinner, R.D., Garcia-Rill, E., Modafinil increases arousal determined by P13 potential am plitude: An effect blocked by gap junction antagonists (2008) Sleep, 31 (12), pp. 1647-1654
dc.descriptionFerraro, L., Tanganelli, S., O'Connor, W.T., Antonelli, T., Rambert, F., Fuxe, K., The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: Possible involvement of the serotonergic 5-HT3 receptor (1996) Neuroscience Letters, 220 (1), pp. 5-8. , DOI 10.1016/S0304-3940(96)13212-2, PII S0304394096132122
dc.descriptionFerraro, L., Antonelli, T., O'Connor, W.T., Tanganelli, S., Rambert, F., Fuxe, K., The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus (1997) NeuroReport, 8 (13), pp. 2883-2887
dc.descriptionDe La Mora, M.P., Aguilar-Garcia, A., Ramon-Frias, T., Ramirez-Ramirez, R., Mendez-Franco, J., Rambert, F., Fuxe, K., Effects of the vigilance promoting drug modafinil on the synthesis of GABA and glutamate in slices of rat hypothalamus (1999) Neuroscience Letters, 259 (3), pp. 181-185. , DOI 10.1016/S0304-3940(98)00905-7, PII S0304394098009057
dc.descriptionWillie, J.T., Renthal, W., Chemelli, R.M., Miller, M.S., Scammell, T.E., Yanagisawa, M., Sinton, C.M., Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates (2005) Neuroscience, 130 (4), pp. 983-995. , DOI 10.1016/j.neuroscience.2004.10.005, PII S0306452204009339
dc.descriptionScammell, T.E., Estabrooke, I.V., McCarthy, M.T., Chemelli, R.M., Yanagisawa, M., Miller, M.S., Saper, C.B., Hypothalamic arousal regions are activated during modafinil-induced wakefulness (2000) J Neurosci, 20 (22), pp. 8620-8628
dc.descriptionRandomized trial of modafinil for the treatment of pathological somnolence in narcolepsy (1998) Ann Neurol, 43 (1), pp. 88-97. , US Modafinil in Narcolepsy Multicenter Study Group
dc.descriptionRandomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy (2000) Neurology, 54 (5), pp. 1166-1175. , US Modafinil in Narcolepsy Multicenter Study Group
dc.descriptionBroughton, R.J., Fleming, J.A.E., George, C.F.P., Hill, J.D., Kryger, M.H., Moldofsky, H., Montplaisir, J.Y., Murphy, W.F., Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy (1997) Neurology, 49 (2), pp. 444-451
dc.descriptionMitler, M.M., Hirsh, J., Hirshkowitz, M., Guilleminault, C., Long-term efficacy and safety of modafinil (PROVIGIL) for the treatment of excessive daytime sleepiness associated with narcolepsy (2000) Sleep Med, 1 (3), pp. 231-243. , for the US Modafinil in Narcolepsy Multicenter Study Group
dc.descriptionMoldofsky, H., Broughton, R.J., Hill, J.D., A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy (2000) Sleep Med, 1 (2), pp. 109-116
dc.descriptionSchwartz, J., Feldman, N.T., Bogan, R.K., Dose response and dose regimen effects of modafinil in sustaining daytime wakefulness in narcoleptic patients with residual excessive sleepiness (2005) J Neuropsychiatry Clin Neurosci, 17 (3), pp. 405-412
dc.descriptionDauvilliers, Y., Neidhart, E., Billiard, M., Tafti, M., Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil (2002) Pharmacogenomics Journal, 2 (1), pp. 65-68. , DOI 10.1038/sj.tpj.6500088
dc.descriptionRobertson Jr., P., Hellriegel, E.T., Clinical pharmacokinetic profile of modafinil (2003) Clin Pharmacokinet, 42 (2), pp. 123-137
dc.descriptionWong, Y.N., Simcoe, D., Hartman, L.N., Laughton, W.B., King, S.P., McCormick, G.C., Grebow, P.E., A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers (1999) Journal of Clinical Pharmacology, 39 (1), pp. 30-40. , DOI 10.1177/00912709922007534
dc.descriptionSchawartz, J.R., Modafinil in the treatment of excessive sleepiness (2009) Drug des Devel Ther, 2, pp. 71-85
dc.descriptionKumar, R., Approved and investigational uses of modafinil: An evidence-based review (2008) Drugs, 68 (13), pp. 1803-1839
dc.descriptionWalsleben, J.A., Ristanovic, R., Hirshkowitz, M., Provigil (modafinil) in the treatment of excessive daytime sleepiness in narcolepsy: Effect of previous treatment with stimulants on clinical response and safety (2000) Sleep, 23, pp. A303-4
dc.descriptionSchwartz, J.R.L., Feldman, N.T., Fry, J.M., Harsh, J., Efficacy and safety of modafinil for improving daytime wakefulness in patients treated previously with psychostimulants (2003) Sleep Medicine, 4 (1), pp. 43-49. , DOI 10.1016/s1389-9457(02)00240-x
dc.descriptionThorpy, M.J., Schwartz, J.R.L., Kovacevic-Ristanovic, R., Hayduk, R., Initiating treatment with modafinil for control of excessive daytime sleepiness in patients switching from methylphenidate: An open-label safety study assessing three strategies (2003) Psychopharmacology, 167 (4), pp. 380-385
dc.descriptionRoth, T., Schwartz, J.R.L., Hirshkowitz, M., Erman, M.K., Dayno, J.M., Arora, S., Evaluation of the safety of modafinil for treatment of excessive sleepiness (2007) Journal of Clinical Sleep Medicine, 3 (6), pp. 595-602
dc.descriptionJasinski, D.R., Kovacevi-Ristanovi, R., Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy (2000) Clin Neuropharmacol, 23 (3), pp. 149-156
dc.descriptionMyrick, H., Malcolm, R., Taylor, B., LaRowe, S., Modafinil: Preclinical, clinical, and post-marketing surveillance - A review of abuse liability issues (2004) Ann Clin Psychiatry, 16 (2), pp. 101-106
dc.descriptionJasisnki, D.R., An evaluation of the abuse potential of modafinil using methylphenidate as a reference (2000) J Psychopharmacol, 14 (1), pp. 53-60
dc.descriptionAndersen, M.L., Kessler, E., Murnane, K.S., McClung, J.C., Tufik, S., Howell, L.L., Dopamine transporter-related effects of modafinil in rhesus monkeys (2010) Pshychopharmacology, 210 (3), pp. 439-448. , Berl
dc.descriptionProvigil Consumer Information, , www.fda.gov/cder/consumerinfo/druginfo/provigil, [cited 2009 mar 2]. Available from
dc.descriptionBogan, R.K., Armodafinil in the treatment of excessive sleepiness (2010) Expert Opin Pharmacother, 11 (6), pp. 993-1002
dc.descriptionNishino, S., Okuro, M., Emerging treatments for narcolepsy and its related disorders (2010) Expert Opin Emerg Drugs, 15 (1), pp. 139-158
dc.descriptionAuger, R.R., Goodman, S.H., Silber, M.H., Krahn, L.E., Pankratz, V.S., Slocumb, N.L., Risks of high-dose stimulants in the treatment of disorders of excessive somnolence: A case-control study (2005) Sleep, 28 (6), pp. 667-672
dc.descriptionDauvilliers, Y., Arnulf, I., Mignot, E., Narcolepsy with cataplexy (2007) Lancet, 369 (9560), pp. 499-511
dc.descriptionMitler, M.M., Hajdukovik, R., Relative efficacy of drugs used for the treatment of narcolepsy (1991) Sleep, 14 (3), pp. 218-220
dc.descriptionWallin, M.T., Mahowald, M.W., Blood pressure effects of long-term stimulant use in disorders of hypersomnolence (1998) J Sleep Res, 7 (3), pp. 209-215
dc.descriptionThorpy, M., Current concepts in the etiology, diagnosis and treatment of narcolepsy (2001) Sleep Med, 2 (1), pp. 5-17
dc.descriptionMitler, M.M., Aldrich, M.S., Koob, G.F., Zarcone, V.P., Narcolepsy and its treatment with stimulants. ASDA standards of practice (1994) Sleep, 17 (4), pp. 352-371
dc.descriptionShindler, J., Schachter, M., Brincat, S., Parkes, J.D., Amphetamine, mazindol, and fencamfamin in narcolepsy (1985) Br Med J (Clin Res Ed), 290 (6476), pp. 1167-1170
dc.descriptionLijima, S., Sugita, Y., Teshima, Y., Hishikawa, Y., Therapeutic effects of mazindol on narcolepsy (1986) Sleep, 9 (1 PART 2), pp. 265-268
dc.descriptionAlvarez, B., Dahlitz, M., Grimshaw, J., Parkes, J.D., Mazindol in long-term treatment of narcolepsy (1991) Lancet, 337 (8752), pp. 1293-1294
dc.descriptionMayer, G., Meier-Ewert, K., Selegiline hydrochloride treatment in narcolepsy. A double-blind, placebo-controlled study (1995) Clin Neuropharmacol, 18 (4), pp. 306-319
dc.descriptionHublin, C., Partinen, M., Heinonen, E., Puuka, P., Salmi, T., Selegiline in the treatment of narcolepsy (1994) Neurology, 44 (11), pp. 2095-2101
dc.descriptionPratt, D.S., Dubois, R.S., Hepatotoxicity due to pemoline (Cylert): A report of two cases (1990) J Pediatr Gastroent Nutri, 10 (2), pp. 239-241
dc.descriptionNehra, A., Mullick, F., Ishak, K.G., Zimmerman, H.J., Pemoline-associated hepatic injury (1990) Gastroenterol, 99 (5), pp. 1517-1519
dc.descriptionBeaumont, M., Batejat, D., Pierard, C., Coste, O., Doireau, P., Van Beers, P., Chauffard, F., Lagarde, D., Slow release caffeine and prolonged (64-h) continuous wakefulness: Effects on vigilance and cognitive performance (2001) Journal of Sleep Research, 10 (4), pp. 265-276. , DOI 10.1046/j.1365-2869.2001.00266.x
dc.descriptionHoughton, W.C., Scammell, T.E., Thorpy, M., Pharmacotherapy for cataplexy (2004) Sleep Med Rev, 8 (5), pp. 355-366
dc.descriptionVignatelli, L., D'Alessandro, R., Candelise, L., Antidepressant drugs for narcolepsy (2005) Cochrane Database Syst Rev, 20, p. 3. , CD0003724
dc.descriptionFrey, J., Darbonne, C., Fluoxetine suppresses human cataplexy: A pilot study (1994) Neurology, 44 (4), pp. 707-709
dc.descriptionPoceta, J.S., Hajdukovic, R., Mitler, M.M., Improvement in cataplexy with yohimbine and paroxetine: Case report (1994) Sleep Res, 23, p. 304
dc.descriptionThirumalai, S.S., Shubin, R.A., The use of citalopram in resistant cataplexy (2000) Sleep Med, 1 (4), pp. 313-316
dc.descriptionSmith, M., Parkes, J.D., Dahlitz, M., Venlafaxine in the treatment of the narcoleptic syndrome (1996) J Sleep Res, 5, p. 217
dc.descriptionLarrosa, O., De La Llave, Y., Bario, S., Granizo, J.J., Garcia-Bor Reguero, D., Stimulant and anticataplectic effects of reboxetine in patients with narcolepsy: A pilot study (2001) Sleep, 24 (3), pp. 282-285
dc.descriptionMayer, G., Meier-Ewert, K., Selegiline hydrochloride treatment in narcolepsy. A double-blind, placebo-controlled study (1995) Clin Neuropharmacol, 18 (4), pp. 306-319
dc.descriptionA randomized, double-blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy (2002) Sleep, 25 (1), pp. 42-49. , US XYREM Multicenter Study Group
dc.descriptionFurther evidence support ing the use of sodium oxybate for the treatment of cataplexy: A double-blind, placebo-controlled study in 228 patients (2005) Sleep Med, 6 (5), pp. 415-421. , U.S. XYREM Multicenter Study Group
dc.descriptionA double-blind placebo controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy (2005) J Clin Sleep Med, 1 (4), pp. 391-397. , XYREM International Study Group
dc.descriptionBlack, J., Houghton, W.C., Sodium oxybate improves excessive daytime sleepiness in narcolepsy (2006) Sleep, 29 (7), pp. 939-946
dc.descriptionLammers, G.J., Bassetti, C., Billiard, M., Black, J., Broughton, R., Dauvilliers, Y., Ferini Strambi, L., Thorpy, M., Sodium oxybate is an effective and safe treatment for narcolepsy (2010) Sleep Med, 11 (1), pp. 105-106
dc.descriptionGrozinger, M., Hartter, S., Hiemke, C., Griese, E.-U., Roschke, J., Interaction of modafinil and clomipramine as comedication in a narcoleptic patient (1998) Clinical Neuropharmacology, 21 (2), pp. 127-129
dc.descriptionWu, D., Victoria Otton, S., Inaba, T., Kalow, W., Sellers, E.M., Interactions of amphetamine analogs with human liver CYP2D6 (1997) Biochemical Pharmacology, 53 (11), pp. 1605-1612. , DOI 10.1016/S0006-2952(97)00014-2, PII S0006295297000142
dc.descriptionThorpy, M.J., Snyder, M., Aloe, F.S., Ledereich, P.S., Starz, K.E., Short-term triazolam use improves nocturnal sleep of narcoleptics (1992) Sleep, 15 (3), pp. 212-216
dc.descriptionBonakis, A., Howard, R.S., Ebrahim, I.O., Merritt, S., Williams, A., REM sleep behaviour disorder (RBD) and its associations in young patients (2009) Sleep Med, 10 (6), pp. 641-645
dc.descriptionSuzanne Hoover-Stevens, S., Ruzica Kovacevic-Ristanovic, R., Management of narcolepsy in pregnancy (2000) CIin Neuropharmacol, 23 (4), pp. 175-181
dc.descriptionRogers, A.E., Aldrich, M.S., Berrios, A.M., Rosenberg, R.S., Compliance with stimulant medications in patients with narcolepsy (1997) Sleep, 20 (1), pp. 28-33
dc.languagept
dc.languageen
dc.publisher
dc.relationRevista Brasileira de Psiquiatria
dc.rightsaberto
dc.sourceScopus
dc.titleBrazilian Guidelines For The Treatment Of Narcolepsy [diretrizes Brasileiras Para O Tratamento Da Narcolepsia]
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución